Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 25, Issue 1, Pages 119-129
Publisher
Springer Nature
Online
2018-11-15
DOI
10.1038/s41591-018-0243-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
- (2018) Constantine S. Tam et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia
- (2018) Carmen D. Herling et al. Nature Communications
- Minimal residual disease in mantle cell lymphoma: are we ready for a personalized treatment approach?
- (2017) Simone Ferrero et al. HAEMATOLOGICA
- Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
- (2017) Matthew S. Davids et al. JOURNAL OF CLINICAL ONCOLOGY
- Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma
- (2017) Steven Le Gouill et al. NEW ENGLAND JOURNAL OF MEDICINE
- The cancer epigenome: Concepts, challenges, and therapeutic opportunities
- (2017) Mark A. Dawson SCIENCE
- Minimal residual disease in mantle cell lymphoma: are we ready for a personalized treatment approach?
- (2017) Simone Ferrero et al. HAEMATOLOGICA
- Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma
- (2016) Nakhle S. Saba et al. BLOOD
- The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism
- (2016) M. A. Anderson et al. BLOOD
- Mantle Cell Lymphoma
- (2016) Chan Yoon Cheah et al. JOURNAL OF CLINICAL ONCOLOGY
- Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study
- (2016) Martin Dreyling et al. LANCET
- FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma
- (2016) Y Li et al. ONCOGENE
- High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma
- (2015) M.-H. Delfau-Larue et al. BLOOD
- Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients
- (2015) S Q Wong et al. BRITISH JOURNAL OF CANCER
- UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas
- (2015) S. Q. Wong et al. CANCER RESEARCH
- Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study
- (2015) M. Cheminant et al. HAEMATOLOGICA
- BET inhibitor resistance emerges from leukaemia stem cells
- (2015) Chun Yew Fong et al. NATURE
- HISAT: a fast spliced aligner with low memory requirements
- (2015) Daehwan Kim et al. NATURE METHODS
- Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
- (2015) Joel D. Leverson et al. Science Translational Medicine
- Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study
- (2015) M. Cheminant et al. HAEMATOLOGICA
- Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics
- (2015) C. Kadoch et al. Science Advances
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells
- (2014) J. Zhang et al. BLOOD
- Combination of ibrutinib with ABT-199: synergistic effects on proliferation inhibition and apoptosis in mantle cell lymphoma cells through perturbation of BTK, AKT and BCL2 pathways
- (2014) Xiaoxian Zhao et al. BRITISH JOURNAL OF HAEMATOLOGY
- SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma - a Nordic Lymphoma Group study
- (2014) Lena Nordström et al. BRITISH JOURNAL OF HAEMATOLOGY
- DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly
- (2014) Ilari Scheinin et al. GENOME RESEARCH
- Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
- (2014) Jennifer A. Woyach et al. NEW ENGLAND JOURNAL OF MEDICINE
- The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma
- (2013) B. Meissner et al. BLOOD
- Combinatorial drug screening identifies synergistic co-targeting of Bruton’s tyrosine kinase and the proteasome in mantle cell lymphoma
- (2013) M Axelrod et al. LEUKEMIA
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma
- (2013) Rami Rahal et al. NATURE MEDICINE
- Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
- (2013) Michael L. Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
- (2013) S. Bea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
- (2012) D. C. Koboldt et al. GENOME RESEARCH
- Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
- (2011) R. Kridel et al. BLOOD
- Impact of TP53 mutation and 17p deletion in mantle cell lymphoma
- (2011) A M Halldórsdóttir et al. LEUKEMIA
- Integrative genomics viewer
- (2011) James T Robinson et al. NATURE BIOTECHNOLOGY
- A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma
- (2011) E. Beltran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
- BEDTools: a flexible suite of utilities for comparing genomic features
- (2010) Aaron R. Quinlan et al. BIOINFORMATICS
- Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling
- (2010) E. M. Hartmann et al. BLOOD
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now